Source - RNS
RNS Number : 5615J
EKF Diagnostics Holdings PLC
12 September 2016
 

12 September 2016

 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Grant of Options

 

EKF Diagnostics Holdings plc (AIM: EKF) announces that, on 12 September 2016, the Company granted options ("Options") over a total of 6,600,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's Unapproved Share Option Plan. Of these Options, 5,800,000 were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company, with 800,000 granted to one other employee.

 

All Options will vest on 12 September 2019 subject to achievement by the individual recipient of specific performance-related criteria and continuous employment, except that they will vest automatically upon the sale of the Company. The Options are exercisable at 15 pence per Ordinary Share, with an expiry date for exercise of 12 September 2026.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Steven Wray - Head of Sales EMEA

Gilbert Mejia - Head of Sales Americas

Martyn Lewis - Head of Marketing

Peter Coyne - Head of Operations

Ed Hitchler - General Manager, EKF USA

Steffan Borlich - General Manager, EKF Germany

Salim Hamir - Company Secretary and Head of Corporate Affairs

Colin Anderson - Deputy Finance Director

 

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of EKF

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI


4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

In each case, the grant of Options on 12 September 2016 over Ordinary Shares

b)

Identification code 

 

GB0031509804

c)

 

Nature of the transaction 

 

Grant of Options over Ordinary Shares pursuant to the Company's Unapproved Share Option plan

 

d)

 

Price(s) and volume(s)

Price - n/a

Volume(s)

Steven Wray - 800,000 Options

Gilbert Mejia - 800,000 Options

Martyn Lewis - 800,000 Options

Peter Coyne - 800,000 Options

Ed Hitchler - 800,000 Options

Steffan Borlich - 800,000 Options

Salim Hamir -500,000 Options

Colin Anderson - 500,000 Options

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 N/a

 

e)

 

Date of the transaction 

12 September 2016

f)

 

Place of the transaction

Outside a trading venue

 

Name of authorised official of issuer responsible for making notification.

Salim Hamir

Company Secretary to EKF Diagnostics Holdings plc

For further information:

EKF Diagnostics Holdings plc   

Tel: 029 2071 0570

Julian Baines, CEO 


Richard Evans, FD & COO




Panmure Gordon (UK) Limited

Tel: 020 7886 2500

Peter Steel


Freddy Crossley




Walbrook PR Limited

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303




 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGCGDCGDBBGLD